310
Views
4
CrossRef citations to date
0
Altmetric
Review

Proteomics applied to pediatric medicine: opportunities and challenges

, , , , , , , , & show all
Pages 883-894 | Received 15 Jun 2016, Accepted 04 Aug 2016, Published online: 25 Aug 2016

References

  • Messana I, Cabras T, Iavarone F, et al. Unraveling the different proteomic platforms. J Sep Sci. 2013;36:128–139.
  • Xiong W, Abraham PE, Li Z, et al. Microbial metaproteomics for characterizing the range of metabolic functions and activities of human gut microbiota. Proteomics. 2015;15:3424–3438.
  • Yu H-R, Kuo H-C, Huang H-C, et al. Identification of immunodeficient molecules in neonatal mononuclear cells by proteomic differential displays. Proteomics. 2011;11:3491–3550. Erratum in Proteomics 011; 11:3942.
  • Zhu J, Zhang H, Guo T, et al. Quantitative proteomics reveals differential biological processes in healthy neonatal cord neutrophils and adult neutrophils. Proteomics. 2014;14:1688–1697.
  • Cini C, Yip C, Attard C, et al. Differences in the resting platelet proteome and platelet releasate between healthy children and adults. J Proteomics. 2015;123:78–88.
  • Tsangaris GT, Kolialexi A, Karamessinis PM, et al. The normal human amniotic fluid supernatant proteome. In Vivo. 2006;20:479–490.
  • Michaels JE, Dasari S, Pereira L, et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. J Proteome Res. 2007;6:1277–1285.
  • Fiddler M. Fetal cell based prenatal diagnosis: perspectives on the present and future. J Clin Med. 2014;3:972–985.
  • Norwitz ER, Phaneuf LE, Levy B. Noninvasive prenatal testing: the future is now. Rev Obstet Gynecol. 2013;6:48–62.
  • Romani R, Fallarino F, Pirisinu I, et al. Comparative proteomic analysis of two distinct stem-cell populations from human amniotic fluid. Mol Biosyst. 2015;11:1622–1632.
  • Roubelakis MG, Tsaknakis G, Pappa KI, et al. Splindle shaped human mesenchimal stem/stromal cells from amniotic fluid promote neovascularization. PLoS One. 2013;8:e54747.
  • Chen C-P, Lai T-C, Chern S-R, et al. Proteome differences between male and female fetal cells in amniotic fluid. Omics. 2013;17:16–26.
  • Castagnola M, Inzitari R, Fanali C, et al. The surprising composition of salivary proteome of preterm human newborns. Mol Cell Proteomics. 2011;10:M110.003467.
  • Tabak LA. A revolution in biomedical assessment: the development of salivary diagnostics. J Dent Educ. 2001;65:1335–1339.
  • Mischke D, Korge BP, Marenholz I, et al. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (“epidermal differentiation complex”) on human chromosome 1q21. J Invest Dermatol. 1996;106:989–992.
  • Feldman AS, Banyard J, Wu C-L, et al. Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin Cancer Res. 2009;15:1024–1031.
  • Srikrishna G. S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun. 2011;4:31–40.
  • Qi Z, Li T, Kong F, et al. The characteristics and function of s100a7 induction in squamous cell carcinoma: heterogeneity, promotion of cell proliferation and suppression of differentiation. PLoS One. 2015;10:e0128887.
  • Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111.
  • Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Investig Dermatol. 2008;128:2365–2380.
  • Nemolato S, Messana I, Cabras T, et al. Thymosin beta(4) and beta(10) levels in pre-term newborn oral cavity and foetal salivary glands evidence a switch of secretion during foetal development. PLoS One. 2009;4:e5109.
  • Nemolato S, Cabras T, Cau F, et al. Different thymosin Beta 4 immunoreactivity in foetal and adult gastrointestinal tract. PLoS One. 2010;5:e9111.
  • Nemolato S, Cabras T, Fanari MU, et al. Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract. Eur J Histochem. 2010;54:e43.
  • Gerosa C, Fanni D, Nemolato S, et al. Thymosin beta-10 expression in developing human kidney. J Matern Fetal Neonatal Med. 2010;23(Suppl3):125–128.
  • Fanni D, Gerosa C, Nemolato S, et al. Thymosin beta 10 expression in developing human salivary glands. Early Hum Dev. 2011;87:779–783.
  • Faa G, Nemolato S, Cabras T, et al. Thymosin β4 expression reveals intriguing similarities between fetal and cancer cells. Ann N Y Acad Sci. 2012;1269:53–60.
  • Manconi B, Cabras T, Pisano E, et al. Modifications of the acidic soluble salivary proteome in human children from birth to the age of 48 months investigated by a top-down HPLC-ESI-MS platform. J Proteomics. 2013;91:536–543.
  • Messana I, Cabras T, Iavarone F, et al. Chrono-proteomics of human saliva: variations of the salivary proteome during human development. J Proteome Res. 2015;14:1666–1677.
  • Morzel M, Jeannin A, Lucchi G, et al. Human infant saliva peptidome is modified with age and diet transition. J Proteomics. 2012;75:3665–3673.
  • Morzel M, Chabanet C, Schwartz C, et al. Salivary protein profiles are linked to bitter taste acceptance in infants. Eur J Pediatr. 2014;173:575–582.
  • Morzel M, Neyraud E, Brignot H, et al. Multi-omics profiling reveals that eating difficulties developed consecutively to artificial nutrition in the neonatal period are associated to specific saliva composition. J Proteomics. 2015;128:105–112.
  • Consonni S, Mainini V, Pizzardi A, et al. Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach. Arch Gynecol Obstet. 2014;289:299–306.
  • Andersson B, Decker R, Nierop AF, et al. Protein profiling identified dissociations between growth hormone mediated longitudinal growth and bone mineralization in short prepubertal children. J Proteomics. 2011;74:89–100.
  • Ruis-González MD, Cañete MD, Gómez-Chaparro JL, et al. Alterations of protein expression in serum of infants with intrauterine growth restriction and different gestational ages. J Proteomics. 2015;119:169–182.
  • Hepponstall M, Ignjatovic V, Binos S, et al. Cardipulmonary bypass changes the plasma proteome in children undergoing tetralogy of Fallot repair. Perfusion. 2015;30:556–564.
  • Gao W, Lu C, Kochanek PM, et al. Serum amyloid A is increased in children with abusive head trauma: a gel-based proteomic analysis. Pediatr Res. 2014;76:280–286.
  • Walker GE, Ricotti R, Roccio M, et al. Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions. PLoS One. 2014;9:e83685.
  • Hathout Y, Brody E, Clemens PR, et al. Large-scale serum protein biomarkers discovery in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2015;112:7153–7158.
  • An D, Wei X, Li H, et al. Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics. Sci Rep. 2015;5:17559.
  • Liu F, Zhao C, Liu L, et al. Peptidome profiling of umbilical cord plasma associated with gestational diabetes-induced macrosomia. J Proteomics. 2016;139:38–44.
  • Moulder R, Bhosale SD, Erkkilä T, et al. Serum proteome distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibility. Diabetes. 2015;64:2265–2268.
  • Cabras T, Pisano E, Mastinu A, et al. Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes. Mol Cell Proteomics. 2010;9:2099–2108.
  • Cabras T, Pisano E, Montaldo C, et al. Significant modifications of the salivary proteome potentially associated with complications of down syndrome revealed by top-down proteomics. Mol Cell Proteomics. 2013;12:1844–1852.
  • Peters-Hall JR, Brown KJ, Pillai DK, et al. Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome. Am J Respir Cell Mol Biol. 2015;53:22–32.
  • Magagnotti C, Matassa PG, Bachi A, et al. Calcium signaling-related proteins are associated with broncho-pulmonary dysplasia progression. J Proteomics. 2013;94:401–412.
  • Vento G, Tirone C, Lulli P, et al. Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia. Intensive Care Med. 2009;35:2115–2124.
  • Tirone C, Boccacci S, Inzitari R, et al. Correlation of levels of α-defensins determined by HPLC-ESI-MS in bronchoalveolar lavage fluid with the diagnosis of pneumonia in premature neonates. Pediatr Res. 2010;68:140–144.
  • Vento G, Lio A, Tirone C, et al. Association of high levels of α-defensisns and S100A proteins with Candida mannan detection in bronchoalveolar lavage fluid of preterm neonates. Pediatr Res. 2013;74:19–25.
  • Suresh CP, Saha A, Kaur M, et al. Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome. Clin Exp Nephrol. 2016;20:273–283.
  • Sedic M, Gethings LA, Vissers JP, et al. Label-free mass spectrometry profile of urinary proteins and metabolites from paediatric idiopathic nephrotic syndrome. Biochem Biophys Res Comm. 2014;452:21–26.
  • Bai Y, Liu W, Guo Q, et al. Screening for urinary biomarkers of steroid-resistant nephrotic syndrome in children. Exp Ther Med. 2013;5:860–864.
  • Chevalier RL. Prognostic factors and biomarkers of congenital obstructive nephropathy. Pediatr Nephrol. 2016;31:1411–1420.
  • Trnka P, Ivanova L, Hiatt MJ, et al. Urinary biomarkers in obstructive nephropathy. Clin J Am Soc Nephrol. 2012;7:1567–1575.
  • Gozal D, Jortani S, Snow AB, et al. Two-dimensional differential in gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med. 2009;180:1253–1261.
  • Becker L, Kheirandish-Gozal L, Peris E, et al. Contextualized urinary biomarker analysis facilitate diagnosis of paediatric obstructive sleep apnea. Sleep Med. 2014;15:541–549.
  • Sylvester KG, Ling XB, Liu GY, et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr. 2014;164:607–612.
  • Ng PC, Ang IL, Chiu RW, et al. Host response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest. 2010;120:2989–3000.
  • Murgas Torrazza R, Li N, Young C, et al. Pilot study proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology. 2013;104:234–242.
  • Ng PC, Chan KY, Poon TC. Biomarkers for prediction and diagnosis of necrotizing enterocolitis. Clin Perinatol. 2013;40:149–159.
  • Tsai M-H, Lin T-Y, Hsieh S-Y, et al. Comparative proteomic studies of plasma from children with pneumococcal pneumonia. Scand J Infect Dis. 2009;41:416–424.
  • Bachmann J, Burté F, Pramana S, et al. Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria. PLoS Pathog. 2014;10:e1004038.
  • Perazzo S, Soler-Garcia AA, Hathout Y, et al. Urinary biomarkers of kidney diseases in HIV-infected children. Proteomics Clin Appl. 2015;9:490–500.
  • Oved K, Cohen A, Boico O, et al. A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLoS One. 2015;10:e0120012.
  • Jiang N, Kham SK, Koh GS, et al. Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL). J Proteomics. 2011;74:843–857.
  • Braoudaki M, Lambrou GI, Vougas K, et al. Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner. J Hematol Oncol. 2013;6:52.
  • Van der Sligte NE, Scherpen FJ, Meeuwseen-de Boer TG, et al. Kinase activity profiling reveals active signal transduction pathways in pediatric acute lymphoblastic anemia: a new approach for target discovery. Proteomics. 2015;15:1245–1254.
  • Priola GM, Foster MW, Deal AM, et al. Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: a pilot study. Pediatr Blood Cancer. 2015;62:1190–1194.
  • Rajagopal MU, Hathout Y, MacDonald TJ, et al. Proteomic profiling of cerebrospinal fluid identified prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: a pediatric brain tumor consortium study. Proteomics. 2011;11:935–943.
  • Zanini C, Mandili G, Bertin D, et al. Analysis of different medulloblastoma histotypes by two-dimensional gel and MALDI-TOF. Childs Nerv Syst. 2011;27:2077–2085.
  • Zanini C, Mandili G, Baci D, et al. Proteomic profile modification of anaplastic medulloblastoma after in-vivo radiotherapy: a case study. J Cancer Ther. 2010;1:97–103.
  • Kuo M-F, Wang H-S, Kuo Q-T, et al. High expression of stathmin protein predicts a fulminant course in medulloblastoma. J Neurosurg Pediatr. 2009;4:74–80.
  • Anagnostopoulos AK, Dimas KS, Papathanassiou C, et al. Proteomics studies of childhood pilocytic astrocytoma. J Proteome Res. 2011;10:2555–2565.
  • Ruiz Esparza-Garrido R, Velázquez-Flores MÁ, Diegopérez-Ramírez J, et al. A proteomic approach of pediatric astrocytomas: MiRNAs and network insight. J Proteomics. 2013;94:162–175.
  • Pettorini BL, Inzitari R, Massimi L, et al. The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Childs Nerv Syst. 2010;26:1779–1784.
  • Desiderio C, Martelli C, Rossetti DV, et al. Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid. Childs Nerv Syst. 2013;29:951–960.
  • Martelli C, Iavarone F, Vincenzoni F, et al. Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches. Electrophoresis. 2014;35:2172–2183.
  • Inserra I, Iavarone F, Martelli C, et al. Proteomic study of pilocytic astrocytoma pediatric brain tumor intracystic fluid. J Proteome Res. 2014;13:4594–4606.
  • Desiderio C, D’Angelo L, Rossetti DV, et al. Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa paediatric brain tumours. Proteomics. 2012;12:2158–2166.
  • Zeccola M, Longhi R, Rossetti DV, et al. Development and validation of a capillary electrophoresis tandem mass spectrometry analytical method for the determination of LVV- and VV-hemorphin-7 peptides in cerebrospinal flui. J Chromatogr A. 2012;1267:170–177.
  • Martelli C, Iavarone F, D’Angelo L, et al. Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study. Mol Biosyst. 2015;11:1668–1683.
  • Park YW, Nam MS. Bioactive peptides in milk and dairy products: a review. Korean J Food Sci An. 2015;35:831–840.
  • Roncada P, Stipetich LH, Bonizzi L, et al. Proteomics as a tool to explore human milk in health and disease. J Proteomics. 2013;88:47–57.
  • Roncada P, Piras C, Soggiu A, et al. Farm animal milk proteomic. J Proteomics. 2012;75:4259–4274.
  • D’Alessandro A, Scaloni A, Zolla L. Human milk proteins: an interactomics and updated functional overview. J Proteome Res. 2010;9:3339–3373.
  • Zhang L, de Waard M, Verheijen H, et al. Changes over lactation in breast milk serum proteins involved in the maturation of the immune and digestive system of the infant. J Proteomics. 2016;7:362–365.
  • Zhang L, Boeren S, Hageman JA, et al. Bovine milk proteome in the first 9 days: protein interactions in maturation of the immune and digestive system of the newborn. PLoS One. 2015;10:e0116710.
  • Yu Y, Lasanajak Y, Song X, et al. Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol Cell Proteomics. 2014;13:2944–2960.
  • Guerrero A, Dallas DC, Contreras S, et al. Mechanistic peptidomics: factors that dictate specificity in the formation of endogenous peptides in human milk. Mol Cell Proteomics. 2014;13:3343–3351.
  • Grapov D, Lemay DG, Weber D, et al. The human colostrum whey proteome is altered in gestational diabetes mellitus. J Proteome Res. 2015;14:512–520.
  • D’Auria E, Agostoni C, Giovannini M, et al. Proteomic evaluation of milk from different mammalian species as a substitute for breast milk. Acta Paediatr. 2005;94:1708–1713.
  • Hettinga KA, Reina FM, Boeren S, et al. Differences in the breast milk proteome between allergic and non-allergic mothers. PLoS One. 2015;10:e0122234.
  • Lu J, Liu L, Pang X, et al. Comparative proteomics of milk fat globule membrane in goat colostrum and mature milk. Food Chem. 2016;209:10–16.
  • Mussap M, Ferrari M, Fanos V. Laboratory medicine meets precision medicine: the paradigm of metabolomics in perinatology: proposals from the 4th international conference on neonatal and pediatric laboratory medicine. Clin Chim Acta. 2015;451(Pt A):1–3.
  • Pećina-Šlaus N, Pećina M. Only one health, and so many omics. Cancer Cell Int. 2015;15:64.
  • Fanos V, Van Den Anker J, Noto A, et al. Metabolomics in neonatology: fact or fiction? Semin Fetal Neonatal Med. 2013;18:3–12.
  • Castagnola M, Uda F, Noto A, et al. The triple-I (interactive, intersectoral, interdisciplinary) approach to validate “omics” investigations on body fluids and tissues in perinatal medicine. J Matern Fetal Neonatal Med. 2014;27:58–60.
  • Arnald A, Sara M, Antonio J. Analytical methods in untargeted metabolomics: state of the art in 2015. Front Bioeng Biotechnol. 2015;3:23.
  • Nielsen M. Reinventing discovery: the new era of networked science. Princeton (NJ): Princeton University Press; 2011.
  • Serino M, Chabo C, Burcelin R. Intestinal microbiOMICS to define health and disease in human and mice. Curr Pharmacol Biotechnol. 2012;13:746–758.
  • Faa G, Gerosa C, Fanni D, et al. Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy. J Matern Fetal Neonatal Med. 2013;26(Suppl 2):35–43.
  • Xiong W, Giannone RJ, Morowitz MJ, et al. Development of an enhanced metaproteomic approach for deepening the microbiome characterization of the human infant gut. J Proteome Res. 2015;14:133–141.
  • Gerritsen J, Smidt H, Rijkers GT, et al. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011;6:209–240.
  • Noto A, Fanos V, Dessì A. Metabolomics in newborns. Adv Clin Chem. 2016;74:35–61.
  • Pereira-Fantini PM, Tingay DG. The proteomics of lung injury in childhood: challenges and opportunities. Clinical Proteomics. 2016;13:5.
  • van der Sligte NE, Kampen KR, de Bont ES. Can kinomics and proteomics bridge the gap between pediatric cancers and newly designed kinase inhibitors? Cell Mol Life Sci. 2015;72:3589–3598.
  • Witzany G. Crucial steps to life: from chemical reactions to code using agents. Biosystems. 2016;140:49–57.
  • Fanos V. 10 P pediatrics: notes for the future. J Pediatr Neonat Individual Med. 2016;5:e050101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.